DR. SUNIL G GANDHI MD NPI 1811945231

NPI Details

DR. Sunil G Gandhi, MD is a medical oncology internal medicine in Lecanto, FL with 44 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Sunil G Gandhi, MD NPI is 1811945231. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

521 N LECANTO HWY
FLORIDA CANCER SPECIALISTS P L
LECANTO, FL
ZIP 34461-187
Phone: (352) 746-0707
Fax: (352) 746-6333

The NPI 1811945231 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, ipilimumab, 1 mg (HCPCS:J9228)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron level (HCPCS:83540)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Iron binding capacity (HCPCS:83550)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Magnesium level (HCPCS:83735)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Protein measurement, serum (HCPCS:84165)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Folic acid level, serum (HCPCS:82746)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Uric acid level, blood (HCPCS:84550)
• Injection of drug or substance into vein (HCPCS:96374)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Drawing of blood for a medical problem (HCPCS:99195)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Automated urinalysis test (HCPCS:81003)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Phosphate level (HCPCS:84100)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection, heparin sodium, per 1000 units (HCPCS:J1644)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hemoglobin a1c level (HCPCS:83036)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 5/5/2006 and was last updated on 5/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.